Existing shareholders face loss of SEC-mandated disclosures and likely reduced liquidity as the stock moves further into the OTC market. Monitor for potential delisting from any remaining exchange and for any going-private transaction that may follow. The small shareholder base (121 holders) suggests limited institutional interest — expect continued price deterioration.
Price Chart
Executive Summary
Lyra Therapeutics filed a Form 15-12G to voluntarily terminate its SEC registration and suspend its reporting obligations under Section 12(g) of the Exchange Act, effective April 30, 2026. The company has only 121 holders of record, which is below the threshold requiring continued SEC reporting. This 'going dark' move eliminates public disclosure requirements and likely moves trading to the OTC markets, significantly reducing transparency and liquidity for remaining shareholders.
Key Facts
- Filed Form 15-12G to terminate registration under Section 12(g) and suspend duty to file reports under Sections 13 and 15(d).
- Approximately 121 holders of record as of the certification date.
- Effectiveness date: April 30, 2026.
- Company's common stock is the only class of securities covered; no other classes remain registered.
- Company is already trading on the OTC exchange.
- No indication of a completed merger or acquisition — this is a standalone deregistration.
Financial Impact
No financial figures provided in the filing. The deregistration eliminates ongoing SEC reporting costs but removes transparency for investors.
Risk Factors
- Loss of SEC oversight and public financial reporting increases information asymmetry and risk of adverse events.
- Reduced liquidity may lead to wider bid-ask spreads and difficulty exiting positions.
- Potential for further shareholder value erosion as the company operates without public disclosure requirements.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 15-12G Filing (Primary) | 0001193125-26-194908 |
| Document: 0001193125-26-194908-index-headers.html | 0001193125-26-194908 |
| Document: 0001193125-26-194908-index.html | 0001193125-26-194908 |
| Document: 0001193125-26-194908.txt | 0001193125-26-194908 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Apr 30, 2026 25w ago | 15-12G | $0.7050 $0.5200 | ▲ +26.24% | ▲ +29.35% | $0.1900 (+73.05%) |
Apr 17, 2026 27w ago | 8-K | $0.8046 $0.4221 | ▲ +47.53% | ▲ +53.68% | $0.1900 (+76.39%) |
Apr 17, 2026 27w ago | Press Release | $0.8046 $0.4221 | ▲ +47.53% | ▲ +53.68% | $0.1900 (+76.39%) |
Apr 10, 2026 28w ago | 8-K | $0.6500 $0.7093 | ▼ −9.13% | ▲ +1.20% | $0.1900 (+70.77%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers